Bio-lab data analytics
Open for applications
Bio-lab data analytics
1-20 employees
Open for applications
1-20 employees
To empower every scientist to make breakthrough discoveries and accelerate the development of life-saving therapies.
Jump to section
To empower every scientist to make breakthrough discoveries and accelerate the development of life-saving therapies.
For biologists and bioinformaticians, Watershed supplies a low-code platform to accelerate data analysis and hypothesis testing, creating a faster path to useful insights.
There is no lack of data generated in biological labs, but the specialized programming knowledge required for effective data analysis is not always present in research teams. Watershed's platform is designed to be used with minimal coding skills and is built specifically for multi-omics analysis including bulk-cell analysis, single-cell analysis, and spatial analysis.
By tackling a prevalent industry pain point, Watershed has quickly gained popularity and clientele across big-name organizations including Harvard Medical School and SQZ Biotech. It has also received significant funding that will help to strengthen commercial traction and accelerate product innovation.
Steph
Company Specialist at Welcome to the Jungle
Mar 2023
$14.5m
SERIES A
Jan 2021
$1.7m
SEED
This company has top investors
Mark Kalinich, MD, PhD
(Co-Founder)A Psychiatry resident Physician at Beth Isreal Deaconess Medical Center, who has worked as Lead Scientist at nference and completed undergraduate research at Langer Laboratories. Earned an MD/PhD from Harvard.
Jonathan Wang
(Co-Founder & CEO)Previously co-founded Domeyard LP. Earned a Bachelor’s and Master’s Degree in Electrical Engineering and Computer Science from MIT.
Software Engineering
Marketing